The book provides comprehensive coverage of innovations in the management of capsula-confined and metastatic endocrine-responsive and endocrine-unresponsive prostate cancer. Besides detailed chapters on the entire range of treatment options, there are background chapters on the epidemiology, development, and natural history of the untreated disease. The controversial issue of the value of prostate-specific antigen as a screening tool is also fully discussed. All chapters have been written by internationally recognized experts in their fields.This volume is an authoritative review of treatment concepts that will appeal to all concerned with the diagnosis and treatment of carcinoma of the prostate.